The short version
4 companies supply this market — a reasonable cushion if one runs into trouble.
The numbers behind every sentence are on this page below — and the Watch button emails you when any of them move.
Pentamidine Isethionate
Pentamidine Isethionate · PENTAMIDINE DIISETHIONATE 300 mg/300mg · Inhalant · Respiratory (Inhalation) · PAI Holdings, LLC dba PAI Pharma
NDC 00121-1102-55 · 1 VIAL in 1 CARTON / 300 mg in 1 VIAL · ANDA · View full market →
Medicare Part D
No Medicare Part D plan in CMS's quarterly files lists this product. That usually means it is discontinued, a repackager's listing, or a product no plan has added to its formulary.
How Part D pricing works →NADAC price per unit
No NADAC pricing on file for this NDC — NADAC covers drugs dispensed by retail community pharmacies.
Supply fragility
Not scored — fragility is computed for NADAC-priced NDCs.
Regulatory
- Application
- ANDA206667
- TE code
- AN
- Approval date
- Apr 24, 2019
- Patents / exclusivity
- None on file
Shortage history
No FDA shortage reports for this drug or its presentations.
Recalls (this NDC)
No enforcement reports list this package NDC.
Manufacturers of Pentamidine Isethionate (Inhalant)
| Labeler | Strength | First seen | Last seen |
|---|---|---|---|
| Fresenius Kabi USA, LLC | PENTAMIDINE ISETHIONATE 300 mg/6mL | Jul 15, 2026 | Sep 2, 2026 |
| PAI Holdings, LLC dba PAI Pharma | PENTAMIDINE DIISETHIONATE 300 mg/300mg | Jul 15, 2026 | Sep 2, 2026 |
| Seton Pharmaceuticals | PENTAMIDINE ISETHIONATE 300 mg/300mg | Jul 15, 2026 | Sep 2, 2026 |
| XGen Pharmaceuticals DJB, Inc. | PENTAMIDINE ISETHIONATE 300 mg/6mL | Jul 15, 2026 | Sep 2, 2026 |
Roster from daily NDC Directory diffs — first/last seen dates start July 2026.
Cite this page
DrugDashboards, "Pentamidine Isethionate — NDC 00121-1102-55," retrieved September 3, 2026, https://drugdashboards.com/drug/00121110255.
Free to cite with attribution — see how the data is put together.